Aromatase inhibitors and anti-synthetase syndrome

di Mascella, Fabio, Gianni, Lorenzo, Affatato, Alessandra, Fantini, Manuela
Pubblicato in Int J Immunopathol Pharmacol (2016)

Human T-lymphotropic virus type 1 (HTLV-1) prevalence and quantitative detection of DNA proviral load in individuals with indeterminate/positive serological results

di Vitone, Francesca, Gibellini, Davide, Schiavone, Pasqua, D'Antuono, Antonietta, Gianni, Lorenzo, Bon, Isabella, Re, Maria Carla
Pubblicazione 2006

Lipoplatin Treatment in Lung and Breast Cancer

di Fantini, Manuela, Gianni, Lorenzo, Santelmo, Carlotta, Drudi, Fabrizio, Castellani, Cinzia, Affatato, Alessandra, Nicolini, Mario, Ravaioli, Alberto
Pubblicazione 2011

Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience

di Maltoni Roberta, Nanni Oriana, Zumaglini Federica, Milandri Carlo, Gianni Lorenzo, Zoli Wainer, Massa Ilaria, Passardi Alessandro, Frassineti Giovanni, Amadori Dino
Pubblicazione 2006-03-01

Phase II study of gemcitabine, doxorubicin and paclitaxel (GAT) as first-line chemotherapy for metastatic breast cancer: a translational research experience

di Passardi, Alessandro, Massa, Ilaria, Zoli, Wainer, Gianni, Lorenzo, Milandri, Carlo, Zumaglini, Federica, Nanni, Oriana, Maltoni, Roberta, Frassineti, Giovanni Luca, Amadori, Dino
Pubblicazione 2006

Annual Hazard Rates of Recurrence for Breast Cancer During 24 Years of Follow-Up: Results From the International Breast Cancer Study Group Trials I to V

di Colleoni, Marco, Sun, Zhuoxin, Price, Karen N., Karlsson, Per, Forbes, John F., Thürlimann, Beat, Gianni, Lorenzo, Castiglione, Monica, Gelber, Richard D., Coates, Alan S., Goldhirsch, Aron
Pubblicato in J Clin Oncol (2016)

Second non-breast primary cancer following adjuvant therapy for early breast cancer: A report from the International Breast Cancer Study Group

di Gianni, Lorenzo, Gelber, Shari, Ravaioli, Alberto, Price, Karen N., Panzini, Ilaria, Fantini, Manuela, Castiglione-Gertsch, Monica, Pagani, Olivia, Simoncini, Edda, Gelber, Richard D., Coates, Alan S., Goldhirsch, Aron
Pubblicazione 2008

The impact of progesterone receptor expression on prognosis of patients with rapidly proliferating, hormone receptor-positive early breast cancer: a post hoc analysis of the IBIS 3...

di Bravaccini, Sara, Bronte, Giuseppe, Scarpi, Emanuela, Ravaioli, Sara, Maltoni, Roberta, Mangia, Anita, Tumedei, Maria Maddalena, Puccetti, Maurizio, Serra, Patrizia, Gianni, Lorenzo, Amaducci, Laura, Biglia, Nicoletta, Bounous, Valentina, Paradiso, Angelo Virgilio, Silvestrini, Rosella, Amadori, Dino, Rocca, Andrea
Pubblicato in Ther Adv Med Oncol (2020)

Tumor-infiltrating lymphocytes (TILs) are a powerful prognostic marker in patients with triple negative breast cancer enrolled in the IBCSG phase III randomized clinical trial 22-0...

di Pruneri, Giancarlo, Gray, Kathryn P., Vingiani, Andrea, Viale, Giuseppe, Curigliano, Giuseppe, Criscitiello, Carmen, Láng, István, Ruhstaller, Thomas, Gianni, Lorenzo, Goldhirsch, Aron, Kammler, Roswitha, Price, Karen N., Cancello, Giuseppe, Munzone, Elisabetta, Gelber, Richard D., Regan, Meredith M., Colleoni, Marco
Pubblicato in Breast Cancer Res Treat (2016)

Phase II Study of Dehydroepiandrosterone in Androgen Receptor‐Positive Metastatic Breast Cancer

di Pietri, Elisabetta, Massa, Ilaria, Bravaccini, Sara, Ravaioli, Sara, Tumedei, Maria Maddalena, Petracci, Elisabetta, Donati, Caterina, Schirone, Alessio, Piacentini, Federico, Gianni, Lorenzo, Nicolini, Mario, Campadelli, Enrico, Gennari, Alessandra, Saba, Alessandro, Campi, Beatrice, Valmorri, Linda, Andreis, Daniele, Fabbri, Francesco, Amadori, Dino, Rocca, Andrea
Pubblicato in Oncologist (2018)

Adjuvant pegylated liposomal doxorubicin for older women with endocrine nonresponsive breast cancer who are NOT suitable for a “standard chemotherapy regimen”: the CASA randomized...

di Crivellari, Diana, Gray, Kathryn P, Dellapasqua, Silvia, Puglisi, Fabio, Ribi, Karin, Price, Karen N, Láng, István, Gianni, Lorenzo, Spazzapan, Simon, Pinotti, Graziella, Lüthi, Jean-Marc, Gelber, Richard D, Regan, Meredith M, Colleoni, Marco, Castiglione-Gertsch, Monica, Maibach, Rudolf, Rabaglio, Manuela, Coates, Alan S, Goldhirsch, Aron
Pubblicazione 2013

Phase II study of liposomal doxorubicin, docetaxel and trastuzumab in combination with metformin as neoadjuvant therapy for HER2-positive breast cancer

di Rocca, Andrea, Cortesi, Pietro, Cortesi, Laura, Gianni, Lorenzo, Matteucci, Federica, Fantini, Lorenzo, Maestri, Antonio, Giunchi, Donata Casadei, Cavanna, Luigi, Ciani, Rosa, Falcini, Fabio, Bagni, Antonella, Meldoli, Elena, Dall’Agata, Monia, Volpi, Roberta, Andreis, Daniele, Nanni, Oriana, Curcio, Annalisa, Lucchi, Leonardo, Amadori, Dino, Fedeli, Anna
Pubblicato in Ther Adv Med Oncol (2021)

Low-Dose Oral Cyclophosphamide and Methotrexate Maintenance for Hormone Receptor–Negative Early Breast Cancer: International Breast Cancer Study Group Trial 22-00

di Colleoni, Marco, Gray, Kathryn P., Gelber, Shari, Láng, István, Thürlimann, Beat, Gianni, Lorenzo, Abdi, Ehtesham A., Gomez, Henry L., Linderholm, Barbro K., Puglisi, Fabio, Tondini, Carlo, Kralidis, Elena, Eniu, Alexandru, Cagossi, Katia, Rauch, Daniel, Chirgwin, Jacquie, Gelber, Richard D., Regan, Meredith M., Coates, Alan S., Price, Karen N., Viale, Giuseppe, Goldhirsch, Aron
Pubblicato in J Clin Oncol (2016)

Adjuvant Letrozole and Tamoxifen Alone or Sequentially for Postmenopausal Women With Hormone Receptor–Positive Breast Cancer: Long-Term Follow-Up of the BIG 1-98 Trial

di Ruhstaller, Thomas, Giobbie-Hurder, Anita, Colleoni, Marco, Jensen, Maj-Britt, Ejlertsen, Bent, de Azambuja, Evandro, Neven, Patrick, Láng, István, Jakobsen, Erik Hugger, Gladieff, Laurence, Bonnefoi, Hervé, Harvey, Vernon J., Spazzapan, Simon, Tondini, Carlo, Del Mastro, Lucia, Veyret, Corinne, Simoncini, Edda, Gianni, Lorenzo, Rochlitz, Christoph, Kralidis, Elena, Zaman, Khalil, Jassem, Jacek, Piccart-Gebhart, Martine, Di Leo, Angelo, Gelber, Richard D., Coates, Alan S., Goldhirsch, Aron, Thürlimann, Beat, Regan, Meredith M.
Pubblicato in J Clin Oncol (2019)

Is There Still a Role for Endocrine Therapy Alone in HR+/HER2– Advanced Breast Cancer Patients? Results from the Analysis of Two Data Sets of Patients Treated with High-Dose Fulves...

di Cazzaniga, Marina Elena, Verusio, Claudio, Ciccarese, Mariangela, Fumagalli, Alberto, Sartori, Donata, Valerio, Maria Rosaria, Airoldi, Mario, Moretti, Gabriella, Ficorella, Corrado, Gianni, Lorenzo, Michelotti, Andrea, Zambelli, Alberto, Febbraro, Antonio, Generali, Daniele, Pistelli, Mirco, Garrone, Ornella, Musolino, Antonino, Vici, Patrizia, Maur, Michela, Mentuccia, Lucia, La Verde, Nicla, Bianchi, Giulia Valeria, Artale, Salvatore, Blasi, Livio, De Laurentiis, Michelino, Atzori, Francesco, Turletti, Anna, Porpiglia, Mauro, Santini, Daniele, Fabi, Alessandra, Gebbia, Vittorio, Schirone, Alessio, Palumbo, Raffaella, Ferzi, Antonella, Frassoldati, Antonio, Scavelli, Claudio, Clivio, Luca, Giordano, Monica, Donadio, Michela, Biganzoli, Laura, Del Mastro, Lucia, Bisagni, Giancarlo, Livi, Lorenzo, Natoli, Clara, Montemurro, Filippo, Riccardi, Ferdinando, Romagnoli, Emanuela, Marchetti, Paolo, Torri, Valter, Pronzato, Paolo, Mustacchi, Giorgio
Pubblicato in Breast Care (Basel) (2020)